Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC28495 | PPC-NB |
PPC-NB is a glutathione cleavable linker used for the antibody-drug conjugate (ADC).
More description
|
![]() |
DC28494 | N3-Ph-NHS ester |
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More description
|
![]() |
DC28493 | PDdEC-NB |
PDdEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate (ADC).
More description
|
![]() |
DC28492 | Propargyl-PEG4-NHS ester |
Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28491 | Propargyl-O-C1-amido-PEG4-C2-NHS ester |
Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28490 | Propargyl-O-C1-amido-PEG2-C2-NHS ester |
Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28489 | Propargyl-PEG1-NHS ester |
Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28488 | Propargyl-C2-NHS ester |
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28487 | Propargyl-C1-NHS ester |
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
More description
|
![]() |
DC28486 | PDEC-NB |
PDEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate (ADC).
More description
|
![]() |
DC28484 | PEG4-SPDP |
PEG4-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs).
More description
|
![]() |
DC28482 | ZL0580 |
ZL0580, a structurally close analog of ZL0590, induces epigenetic suppression of HIV via selectively binding to BD1 domain of BRD4. ZL0580 induces HIV suppression by inhibiting Tat transactivation and transcription elongation as well as by inducing repressive chromatin structure at the HIV promoter.
More description
|
![]() |
DC28479 | 2-Hydroxy Ibuprofen |
2-Hydroxy Ibuprofen is a metabolite of Ibuprofen. Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50s of 13 μM and 370 μM, respectively.
More description
|
![]() |
DC28478 | KIN101 |
KIN101 is a potent viral inhibitor with IC50s of 2 μM, >5 μM for influenza virus and Dengue virus (DNV), respectively. KIN101 is used for viral infection, including RNA viral infection.
More description
|
![]() |
DC28477 | Gnetol |
Gnetol is a phenolic compound isolated from the root of Gnetum ula Brongn. Gnetol potently inhibits COX-1 (IC50 of 0.78 μM) and HDAC. Gnetol is a potent tyrosinase inhibitor with an IC50 of 4.5 μM for murine tyrosinase and suppresses melanin biosynthesis. Gnetol has antioxidant, antiproliferative, anticancer and hepatoprotective activity. Gnetol also possesses concentration-dependent α-Amylase, α-glucosidase, and adipogenesis activities.
More description
|
![]() |
DC28476 | EPI-589 |
EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS).
More description
|
![]() |
DC28475 | NR1H4 activator 1 |
NR1H4 activator 1 is a potent and selective Famesoid X Receptor (FXR) agonist, extracted from patent WO2018152171A1, example 4. NR1H4 activator 1 shows strong FXR agonistic potency with a EC50 value of 1 nM in a Human FXR (NR1H4) Assay. NR1H4 activator 1 has the potential for treatment of gastrointestinal disease.
More description
|
![]() |
DC28474 | SLC13A5-IN-1 |
SLC13A5-IN-1 is a selective sodium-citrate co-transporter (SLC13A5) inhibitor. SLC13A5-IN-1 completely blocks the uptake of 14C-citrate with an IC50 value of 0.022 μM in HepG2 cells. SLC13A5-IN-1 has the potential for the treatment of metabolic and/or cardiovascular diseases. SLC13A5-IN-1 is extracted from patent WO2018104220A1, Compound I-5.
More description
|
![]() |
DC28473 | Latanoprost lactone diol |
Latanoprost lactone diol is an intermediate in the synthesis of Latanoprost. Latanoprost is a prostaglandin F2α analogue and an agonist for the FP prostanoid receptor, and lowers intraocular-pressure (IOP).
More description
|
![]() |
DC28472 | Allocholic acid |
Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis. Allocholic acid is also a potent and specific stimulant of the adult olfactory system.
More description
|
![]() |
DC28471 | D-Tubocurarine chloride pentahydrate |
D-Tubocurarine chloride pentahydrate is the chloride salt form of Tubocurarine, a nicotinic acetylcholine receptors (AChR) antagonist, and can be used as a skeletal muscle relaxant during surgery or mechanical ventilation. D-Tubocurarine chloride pentahydrate is also a potent neuromuscular blocking agent.
More description
|
![]() |
DC28470 | Phosphatidylcholines,soya |
Phosphatidylcholines,soya is a phosphatidylcholine from soybean used in the preparation of liposomes. Phosphatidylcholines,soya can be used as a vehicle in animal drug administration.
More description
|
![]() |
DC28469 | TGFβRI-IN-2 |
TGFβRI-IN-2 (compound 18) is a potent, selective and orally active (Activin-Like Kinase 5) ALK 5 inhibitor with pIC50 and pEC50 values of 7.6 and 6.63, respectively. TGFβRI-IN-2 can produce observed cardiac toxicity in vivo at high dose.
More description
|
![]() |
DC28468 | MS31 trihydrochloride |
MS31 trihydrochloride is a potent, cell permeable, highly affinity, and highly selective fragment-like methyllysine reader protein spindlin 1 (SPIN1) inhibitor. MS31 trihydrochloride potently inhibits the interactions between SPIN1 and H3K4me3 (IC50=77 nM, AlphaLISA; 243 nM, FP). MS31 trihydrochloride selectively binds Tudor domain II of SPIN1 (Kd=91 nM). MS31 potently inhibits binding of trimethyllysine-containing peptides to SPIN1, and is not toxic to nontumorigenic cells.
More description
|
![]() |
DC28467 | Ganoderic acid Y |
Ganoderic acid Y is a α-glucosidase inhibitor with an IC50 of 170 μM for yeast α-glucosidase. Ganoderic acid Y inhibits enterovirus 71 (EV71) replication through blocking EV71 uncoating.
More description
|
![]() |
DC28466 | Euphorbadienol |
Euphorbadienol (alpha-Euphorbol), a triterpenic compound, isolated from the latex of Euphorbia resinifera. The derivatives of Euphorbadienol can be used as elicitors of disease resistance, and has antileishmanial and antitrypanosomal activity.
More description
|
![]() |
DC28465 | Pitavastatin lactone |
Pitavastatin lactone is a major metabolite of Pitavastatin in humans. Pitavastatin is a potent competitive inhibitor of HMG-CoA reductase little metabolized in hepatic microsomes.
More description
|
![]() |
DC28464 | DBCO-NHCO-PEG4-acid |
DBCO-Amide-PEG5-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More description
|
![]() |
DC28463 | Resolvin D1 |
Resolvin D1 (RvD1), an endogenous pro-resolving mediator of inflammation, is derived from omega-3 docosahexaenoic acid during the resolution phase of acute inflammation. Resolvin D1 blocks proinflammatory neutrophil migration by regulating actin polymerization, reduces TNF-α–mediated inflammation in macrophages, and enhances phagocytosis of apoptotic cells by macrophages.
More description
|
![]() |
DC28462 | Brevetoxin-3 |
Brevetoxin-3 (PbTx-3) is a potent allosteric voltage-gated Na+ channel activator and has multiple active centers (A-ring lactone, C-42 of R side chain). Brevetoxin-3 (PbTx-3) has a high affinity to site 5 of the voltage-sensitive Na+ channels, inhibits the inactivation of Na+ channels and prolongs the mean open time of these channels. Brevetoxin-3 (PbTx-3) repeated exposures can lead to prolonged airway hyperresponsiveness (AHR) and lung inflammation.
More description
|
![]() |